CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-24 | Walts Alan Edmund Director | Option exercise | +1,875 | 15,567 | ||
| 2026-01-24 | Walts Alan Edmund Director | Option exercise · Restricted Stock Units | −1,875 | 1,875 | ||
| 2025-09-19 | Rubin Steven D Director | Grant or award · Stock Option (Right to Buy) | +179,854 | 179,854 | ||
| 2025-09-19 | Aggarwal Sumit President and CEO | Grant or award | +1,000,000 | 1,396,810 | ||
| 2025-09-19 | Aggarwal Sumit President and CEO | Grant or award · Stock Option (Right to Buy) | +3,597,090 | 3,597,090 | ||
| 2025-09-19 | Walts Alan Edmund Director | Grant or award · Stock Option (Right to Buy) | +395,680 | 395,680 | ||
| 2025-08-14 | Aggarwal Sumit President and CEO | Option exercise | +196,880 | $0.00 | $20 | 396,810 |
| 2025-08-14 | Aggarwal Sumit President and CEO | Option exercise · Stock Option (Right to Buy) | −60,390 | 0 | ||
| 2025-08-14 | Aggarwal Sumit President and CEO | Option exercise · Stock Option (Right to Buy) | −68,700 | 0 | ||
| 2025-08-14 | Aggarwal Sumit President and CEO | Option exercise · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2025-08-14 | Aggarwal Sumit President and CEO | Option exercise · Stock Option (Right to Buy) | −42,790 | 0 | ||
| 2025-01-24 | Aggarwal Sumit Director | Option exercise | +30,000 | 199,930 | ||
| 2025-01-24 | Aggarwal Sumit Director | Option exercise · Restricted Stock Units | −30,000 | 30,000 | ||
| 2025-01-24 | Rubin Steven D Director | Option exercise | +3,750 | 15,750 | ||
| 2025-01-24 | Rubin Steven D Director | Option exercise · Restricted Stock Units | −3,750 | 3,750 | ||
| 2025-01-24 | Androski Lindsay Director | Option exercise | +3,750 | 15,750 | ||
| 2025-01-24 | Androski Lindsay Director | Option exercise · Restricted Stock Units | −3,750 | 3,750 | ||
| 2025-01-24 | Walts Alan Edmund Director | Option exercise | +3,750 | 16,692 | ||
| 2025-01-24 | Walts Alan Edmund Director | Option exercise · Restricted Stock Units | −3,750 | 3,750 | ||
| 2024-10-16 | Aggarwal Sumit President and CEO | Returned to the company · Stock Option (Right to Buy) | −42,790 | 0 |
Page 2 of 11 · 206 trades